StockData
Telomir Pharmaceuticals, Inc. logo

Telomir Pharmaceuticals, Inc. (TELO) stock

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.48−0.01 (-1.96%)

Close on Nov 16, 2026Market cap $33.08MP/E –Yield –

Telomir Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Telomir Pharmaceuticals's price to book ratio was 8.1× on Nov 11, 2026, against 6.5× a year earlier. Over the last 3 years it ranged from 5.5× to 325.5×, with a median of 47.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.1×+1.7
2025Dec 31, 20256.4×−269.5
2024Dec 31, 2024275.9×–

More Telomir Pharmaceuticals figures

See a number that looks wrong?